# US 2003/0073636 A1 · Method of treating diabetes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0073636 A1
- Document ID: US20030073636A1
- Status: Published application
- Kind: A1
- Application number: 10/246,644
- Filed: 2002-09-18
- Published: 2003-04-17
- Earliest claimed: 2001-09-19
- Assignees: Oklahoma Medical Research Foundation
- Inventors: Fletcher B. Taylor JR.
- Web page: https://patentgrep.com/patent/US20030073636A1

## CPC

- A61K 38/4866: {Protein C (3.4.21.69)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

It has been discovered that the dysfunction of microvascular endothelium associated with microvascular thrombosis associated with diabetes mellitus can be treated by infusion of activated Protein C. As demonstrated by the example, infusion of an insulin-dependent baboon and normal baboons demonstrated that one can normalize the thrombin-antithrombin (TAT), activated protein C/protein C inhibitor (APC/PCI) and protein C( PC).

## Claims

### Claim 1

A method of treating the dysfunction of microvascular thrombosis associated with diabetes mellitus comprising administering to a patient with diabetes in need thereof an effective amount of activated protein C to alleviate the symptoms associated with the microvascular thrombosis.

### Claim 2 (depends on 1)

The method of claim 1 wherein the activated protein C is recombinant human protein C.

### Claim 3 (depends on 1)

The method of claim 1 wherein the activated protein C is administered intravascularly.
